Gaining the patient perspective on pelvic floor disorders' surgical adverse events.
function outcomes
pelvic floor disorders
qualitative study
surgical adverse events
Journal
American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
12
06
2018
revised:
11
10
2018
accepted:
19
10
2018
pubmed:
8
1
2019
medline:
29
10
2019
entrez:
8
1
2019
Statut:
ppublish
Résumé
The Institute for Healthcare Improvement defines an adverse event as an unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization or that results in death. The majority of research has focused on adverse events from the provider's perspective. The objective of this qualitative study was to describe patient perceptions on adverse events following surgery for pelvic floor disorders. Women representing the following 3 separate surgical populations participated in focus groups: (1) preoperative (women <12 weeks prior to surgery); (2) short-term postoperative (women up to 12 weeks after surgery); and (3) long-term postoperative (women 1-5 years after surgery). Deidentified transcripts of audio recordings were coded and analyzed with NVivo 10 software to identify themes, concepts, and adverse events. Women were asked to rank patient-identified and surgeon-identified adverse events in order of perceived severity. Eighty-one women participated in 12 focus groups. Group demographics were similar between groups, and all groups shared similar perspectives regarding surgical expectations. Women commonly reported an unclear understanding of their surgery and categorized adverse events such as incontinence, constipation, nocturia, and lack of improvement in sexual function as very severe, ranking these comparably with intensive care unit admissions or other major surgical complications. Women also expressed a sense of personal failure and shame if symptoms recurred. Women consider functional outcomes such as incontinence, sexual dysfunction, and recurrence of symptoms as severe adverse events and rate them as similar in severity to intensive care unit admissions and death.
Sections du résumé
BACKGROUND
The Institute for Healthcare Improvement defines an adverse event as an unintended physical injury resulting from or contributed to by medical care that requires additional monitoring, treatment, or hospitalization or that results in death. The majority of research has focused on adverse events from the provider's perspective.
OBJECTIVE
The objective of this qualitative study was to describe patient perceptions on adverse events following surgery for pelvic floor disorders.
STUDY DESIGN
Women representing the following 3 separate surgical populations participated in focus groups: (1) preoperative (women <12 weeks prior to surgery); (2) short-term postoperative (women up to 12 weeks after surgery); and (3) long-term postoperative (women 1-5 years after surgery). Deidentified transcripts of audio recordings were coded and analyzed with NVivo 10 software to identify themes, concepts, and adverse events. Women were asked to rank patient-identified and surgeon-identified adverse events in order of perceived severity.
RESULTS
Eighty-one women participated in 12 focus groups. Group demographics were similar between groups, and all groups shared similar perspectives regarding surgical expectations. Women commonly reported an unclear understanding of their surgery and categorized adverse events such as incontinence, constipation, nocturia, and lack of improvement in sexual function as very severe, ranking these comparably with intensive care unit admissions or other major surgical complications. Women also expressed a sense of personal failure and shame if symptoms recurred.
CONCLUSION
Women consider functional outcomes such as incontinence, sexual dysfunction, and recurrence of symptoms as severe adverse events and rate them as similar in severity to intensive care unit admissions and death.
Identifiants
pubmed: 30612960
pii: S0002-9378(18)30917-7
doi: 10.1016/j.ajog.2018.10.033
pmc: PMC6351201
mid: NIHMS1510815
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
185.e1-185.e10Subventions
Organisme : NICHD NIH HHS
ID : U10 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054215
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001449
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : L30 HD085503
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069025
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.
Références
Obstet Gynecol. 2014 May;123(5):1023-30
pubmed: 24785855
BJOG. 2008 Oct;115(11):1362-8
pubmed: 18715245
N Engl J Med. 2012 Nov 8;367(19):1803-13
pubmed: 23036134
N Engl J Med. 2006 Apr 13;354(15):1557-66
pubmed: 16611949
Int Urogynecol J. 2011 Sep;22(9):1159-63
pubmed: 21604059
N Engl J Med. 2012 Jun 21;366(25):2358-67
pubmed: 22716974
Int Urogynecol J. 2010 May;21(5):523-8
pubmed: 20013110
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Am J Obstet Gynecol. 2003 Dec;189(6):1551-7; discussion 1557-8
pubmed: 14710061
Neurourol Urodyn. 2014 Jan;33(1):85-9
pubmed: 23423738
Am J Obstet Gynecol. 2001 Dec;185(6):1388-95
pubmed: 11744914
Am J Obstet Gynecol. 2013 Jan;208(1):81.e1-9
pubmed: 23131463
J Am Coll Surg. 2008 Aug;207(2):240-5
pubmed: 18656053
Am J Obstet Gynecol. 2008 May;198(5):575.e1-6
pubmed: 18313632
Am J Obstet Gynecol. 2013 Nov;209(5):488.e1-5
pubmed: 23770473
JAMA. 2018 Apr 17;319(15):1554-1565
pubmed: 29677302